| 22-May-13 08:17AM | InPlay: Pluristem Therapeutics announced that Katherina Reiche & Hans-Dieter Volk met; new opportunities discussed to strengthen collaborative relationships using pluristem's placental expanded cells Briefing.com |
| 08:03AM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online |
| 05:30AM | Pluristem Welcomes Parliamentary State Secretary of the German Federal Ministry for Environmental, Nature Conservation and Nuclear Safety and the Chairman of the Charite Berlin-Brandenburg Center for Regenerative Therapies GlobeNewswire |
| 20-May-13 11:38AM | A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 at Seeking Alpha |
| 19-May-13 11:52AM | Cloning: A Stem Cell Revolution? at Motley Fool |
| 14-May-13 01:04PM | PLURISTEM THERAPEUTICS INC Financials EDGAR Online Financials |
| 13-May-13 06:10PM | 3 Healthcare Stock Stories For Monday Investment Wellness at Wall St. Cheat Sheet |
| 06:23AM | Pluristem Therapeutics' PLX cells may be effective in treating preeclampsia at theflyonthewall.com |
| 04:11AM | InPlay: Pluristem Therapeutics provides preclinical research showing PLX Cells may be effective in treating preeclampsia Briefing.com |
| 03:30AM | Preclinical Research Shows PLX Cells May be Effective in Treating Preeclampsia GlobeNewswire |
| 08-May-13 09:45AM | PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 07:12AM | Pluristem Therapeutics announces Phase 1 trial to study PLX-PAD cells at theflyonthewall.com |
| 07:01AM | Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff Repair Marketwired |
| 07:01AM | Pluristem Carving Out Distinct Niche in Orthopedic Medicine With New Clinical Trials in Rotator Cuff Repair Marketwire |
| 07-May-13 03:00AM | Pluristem Develops PLX-RAD Cells for Use in Hematology GlobeNewswire |
| 02-May-13 05:26PM | U.S. judge gives onetime 'King of Biotech' four years in prison at Reuters |
| 30-Apr-13 04:19AM | United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy at Seeking Alpha |
| 03:00AM | Pluristem to Present at Needham Healthcare and Oppenheimer Israeli Investment Conferences in May 2013 GlobeNewswire |
| 29-Apr-13 05:45AM | Pluristem's PLX-PAD Cells' safety in human lung models shown by research study at theflyonthewall.com |
| 03:00AM | Third Party Research Study Demonstrates Pluristem's PLX-PAD Cells' Safety in Human Lung Models of Pulmonary Hypertension GlobeNewswire |
| 19-Apr-13 08:07PM | 3 Healthcare Stock Stories For Weekend Investment Wellness at Wall St. Cheat Sheet |
| 03:30PM | PSTI Plans to Start Phase I Study Zacks |
| 18-Apr-13 03:00AM | Pluristem Expands PLX Product Portfolio in Orthopedics and Sports Medicine GlobeNewswire |
| 17-Apr-13 08:24AM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other Events EDGAR Online |
| 15-Apr-13 11:00AM | UTHR to Move PAH Drug into Phase I Zacks |
| 12-Apr-13 01:45PM | 4 Healthcare Stock Stories for Weekend Investment Wellness at Wall St. Cheat Sheet |
| 11-Apr-13 03:19AM | InPlay: Pluristem Therapeutics: United Therapeutics receives regulatory approval to commence Phase I study of Pluristem's PLX-PAD cells for pulmonary arterial hypertension Briefing.com |
| 03:00AM | United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension GlobeNewswire |
| 10-Apr-13 04:00AM | The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy at Seeking Alpha |
| 02:00AM | Pluristem Announces Scientific and Investment Conferences for April 2013 GlobeNewswire |
| 28-Mar-13 09:14AM | Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy at Seeking Alpha |
| 20-Mar-13 03:55AM | InPlay: Pluristem Therapeutics reports on the progress of its Phase I/II clinical trial for the treatment of muscle injury Briefing.com |
| 03:26AM | Phase II Trials Will Be Pivotal For These Stem Cell Companies at Seeking Alpha |
| 03:00AM | Pluristem Reports on the Progress of Its Phase I/II Clinical Trial for the Treatment of Muscle Injury GlobeNewswire |
| 19-Mar-13 09:32AM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other Events EDGAR Online |
| 18-Mar-13 04:40PM | After-Hours Buzz: EA, BAC, DFS & More at CNBC |
| 04-Mar-13 04:53PM | Pluristem & UTHR Progress with PLX-PAD Zacks |
| 28-Feb-13 02:15PM | 2012 Stem Cell Standouts And The Outlook For 2013 at Seeking Alpha |
| 27-Feb-13 05:25AM | New Orphan Drug Designation For Pluristem Could Gain Access To FDA 'Progressive Approval' at Seeking Alpha |
| 26-Feb-13 09:11AM | Pluristem Therapeutics moves toward Phase I study of PLX-PAD Cells for PAH at theflyonthewall.com |
| 09:00AM | United Therapeutics Moves Forward Towards a Phase I Study of Pluristem's PLX-PAD Cells for Pulmonary Arterial Hypertension GlobeNewswire |
| 25-Feb-13 11:46AM | Pluristem Therapeutics, Inc. Announces Its Sr. VP of Corporate Development Will Be Presenting at the Accredited Members Spring Micro Cap Investor Conference in Las Vegas Marketwire |
| 21-Feb-13 08:59PM | Pluristem Gets FDA's Orphan Drug Nod for Anemia Treatment at Motley Fool |
| 11:15AM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other Events EDGAR Online |
| 08:01AM | 4 Biotech Stocks Under $10 Moving Higher at TheStreet |
| 04:12AM | InPlay: Pluristem Therapeutics receives FDA Orphan Drug status designation for treatment of aplastic anemia Briefing.com |
| 02:30AM | Pluristem Receives FDA Orphan Drug Status Designation for Treatment of Aplastic Anemia GlobeNewswire |
| 15-Feb-13 08:20AM | U.S. Food and Drug Administration Approved 30% More Drugs in 2012 Than the Year Previous Marketwire |
| 13-Feb-13 07:56AM | CORRECTING AND REPLACING -- Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13 GlobeNewswire |
| 03:00AM | Pluristem CEO to Participate in Key Roundtable Discussion at the 8th Annual New York Stem Cell Summit '13 GlobeNewswire |
| 06-Feb-13 01:04PM | PLURISTEM THERAPEUTICS INC Financials EDGAR Online Financials |
| 31-Jan-13 04:51PM | PLURISTEM THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 04:38PM | Pluristem Moves to New Facility Zacks |
| 30-Jan-13 03:00AM | Pluristem Takes Possession of and Moving Into New State-of-the-Art Manufacturing Facility GlobeNewswire |
| 22-Jan-13 09:33AM | 3 Regenerative Medicine Companies That Could Deliver In 2013 at Seeking Alpha |
| 08:00AM | Pluristem Updates Cell Manufacturing Industry on Its Proprietary 3D Cell Expansion Technology at Industry Conference GlobeNewswire |
| 07:25AM | Athersys: Short Term Catalyst With Long Term Potential Marketwire |
| 18-Jan-13 07:01AM | Rumors, News and Biotech Buzz Present Various Trade Opportunities Marketwire |
| 16-Jan-13 10:18AM | Why Pluristem Therapeutics Is Poised to Plunge at Motley Fool |
| 08:20AM | Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013 Marketwire |
| 15-Jan-13 02:03PM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Other Events EDGAR Online +6.79% |
| 01:42PM | InPlay from Briefing.com Briefing.com |
| 01:03PM | InPlay from Briefing.com Briefing.com |
| 12:15PM | InPlay from Briefing.com Briefing.com |
| 11:54AM | InPlay from Briefing.com Briefing.com |
| 11:17AM | InPlay from Briefing.com Briefing.com |
| 10:40AM | InPlay from Briefing.com Briefing.com |
| 10:03AM | InPlay from Briefing.com Briefing.com |
| 09:21AM | InPlay from Briefing.com Briefing.com |
| 08:53AM | InPlay from Briefing.com Briefing.com |
| 08:13AM | InPlay from Briefing.com Briefing.com |
| 07:43AM | InPlay from Briefing.com Briefing.com |
| 07:08AM | InPlay from Briefing.com Briefing.com |
| 06:32AM | InPlay from Briefing.com Briefing.com |
| 05:56AM | InPlay from Briefing.com Briefing.com |
| 05:20AM | InPlay from Briefing.com Briefing.com |
| 04:32AM | InPlay from Briefing.com Briefing.com |
| 04:30AM | InPlay: Pluristem Therapeutics receives approval to expand its Phase II clinical trial in intermittent claudication to Germany Briefing.com |
| 04:00AM | Pluristem Receives Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Germany GlobeNewswire |
| 07-Jan-13 04:06PM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online |
| 07:00AM | Pluristem's CEO Letter to Shareholders GlobeNewswire |
| 04-Jan-13 06:26PM | Pluristem Progresses with New Facility Zacks |
| 02-Jan-13 04:37PM | Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunity at Seeking Alpha +6.58% |
| 29-Dec-12 10:34AM | 3 Horrendous Health-Care Stocks This Week at Motley Fool |
| 27-Dec-12 03:00AM | Pluristem Initiates Final Validation of New Manufacturing Facility GlobeNewswire -6.38% |
| 26-Dec-12 05:28PM | PLURISTEM THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online |
| 20-Dec-12 07:16PM | The Rosen Law Firm Announces Investigation of Securities Claims Against Pluristem Therapeutics, Inc. --- PSTI Business Wire |
| 14-Dec-12 10:00AM | Has Geron Become the Perfect Stock? at Motley Fool |
| 12-Dec-12 03:00AM | Pluristem to Present at Oppenheimer 23rd Annual Healthcare Conference GlobeNewswire |
| 10-Dec-12 10:29AM | Pluristem Joins Both the TA-75 and TA-100 Indexes on the Tel Aviv Stock Exchange GlobeNewswire |
| 05-Dec-12 06:59PM | Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Field at Seeking Alpha |
| 04-Dec-12 10:03AM | Maxim Group Highlights 3 Stem Cells Stocks To Consider And 1 To Avoid at Seeking Alpha |
| 03:00AM | Pluristem Advances Its Intramuscular Hematology Program; Assembles Clinical Advisory Board of World Renowned Opinion Leaders GlobeNewswire |
| 29-Nov-12 02:56PM | Are Short-Sellers Onto Something at Pluristem Therapeutics? at Motley Fool |
| 27-Nov-12 05:59PM | Orphan Status Update from Pluristem Zacks -5.71% |
| 21-Nov-12 06:01AM | InPlay: Pluristem Therapeutics reports status of orphan drug application for aplastic anemia; FDA acknowledges aplastic anemia as rare disease and requests further data from the co in connection with application Briefing.com |
| 06:00AM | Pluristem Reports Status of Orphan Drug Application for Aplastic Anemia GlobeNewswire |
| 20-Nov-12 09:58AM | 4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce at Seeking Alpha |
| 14-Nov-12 01:04PM | PLURISTEM THERAPEUTICS INC Financials EDGAR Online Financials |
| 07:00AM | Pluristem to Initiate a Phase I/II Clinical Trial in Muscle Injury GlobeNewswire |
